Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression

Maurizio Pieroni, Maria De Santis, Gaetano Zizzo, Silvia Laura Bosello, Costantino Smaldone, Mara Campioni, Giacomo De Luca, Antonella Laria, Agostino Meduri, Fulvio Bellocci, Lorenzo Bonomo, Filippo Crea, Gianfranco Ferraccioli

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Scleroderma heart disease is a major risk of death in systemic sclerosis (SSc). Mechanisms underlying myocardial damage are still unclear. We performed an extensive study of SSc patients with recent-onset symptoms for heart disease and examined the efficacy of immunosuppressive therapy.
Original languageEnglish
Pages (from-to)526-535
Number of pages10
JournalSeminars in Arthritis and Rheumatism
Volume43
DOIs
Publication statusPublished - 2013

Keywords

  • ANCA
  • Heart disease
  • Myocarditis
  • Parvovirus B19
  • Systemic sclerosis
  • Treatment

Fingerprint

Dive into the research topics of 'Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: Potential utility of immunosuppressive therapy in cardiac damage progression'. Together they form a unique fingerprint.

Cite this